Skip to main content
. 2012 Dec 16;2(4):306–314. doi: 10.1016/j.jceh.2012.07.001

Table 1.

Clinical and demographic characteristics of patients.

Parameter Patients screened (n = 187) Patients enrolled (n = 102) MHEa (n = 41) NMHEa (n = 61)
Sex (Male)b 168 (89.8%) 89 (87.3%) 37 (90.2%) 52 (85.2%)
Age (in years)c 47.57 (45.90–49.24) 45.68 (43.38–47.97) 46.68 (42.80–50.57) 45 (42.11–47.89)
CTP Classb
 Class A 71 (38.0%) 54 (52.9%) 16 (39%) 38 (62.3%)
 Class B 74 (39.6%) 35 (34.3%) 16 (39%) 19 (31.1%)
 Class C 42 (22.5%) 13 (12.7) 9 (22%) 4 (6.6%)
MELD scorec 13.26 (12.53–13.98) 11.96 (11.06–12.87) 13.29 (11.78–14.80) 11.07 (9.97–12.17)
Etiologyb
 Alcohol 120 (64.2%) 52 (51%) 23 (56.1%) 29 (47.6%)
 HBV 22 (11.7%) 15 (14.7%) 9 (22.1%) 6 (9.8%)
 HCV 13 (7%) 9 (8.8%) 4 (9.6%) 5 (8.3%)
 Others 32 (17.1%) 26 (25.5%)d 5 (12.2%) 21 (34.3%)
Education in yearsc 11.17 (10.61–11.73) 12.22 (11.67–12.76) 12.39 (11.60–13.18) 12.10 (11.34–12.86)

CTP, Child–Turcotte–Pugh; HBV, hepatitis B virus; HCV, hepatitis C virus; MHE, minimal hepatic encephalopathy; NMHE, non-minimal hepatic encephalopathy.

a

MHE and NMHE columns describe patients who have been enrolled; distinction between the 2 groups was based on the results of psychometric hepatic encephalopathy score.

b

Number (percentage).

c

Mean (95% confidence interval).

d

Non-alcoholic steatohepatitis 5 patients, autoimmune hepatitis 5, and cryptogenic cirrhosis in 14 patients.